Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

PGY-2 Oncology Residency - Pediatrics

The Pharmacy Department at Memorial Sloan Kettering recognizes the value and need for an oncology specialty residency for pharmacists seeking a career in oncology practice.

Purpose

PGY2 pharmacy residency training builds on the foundations of pharmacy practice established during Doctor of Pharmacy (Pharm.D.) education and the PGY1 pharmacy residency experience. The MSKCC PGY2 oncology residency provides residents with a 12 month learning experience that prepares them to function independently as a clinical pharmacy practitioner in oncology, to serve as a fully integrated member of a multi-disciplinary team, and to optimize medications used in the provision of cancer care. Residents who successfully complete a PGY2 oncology pharmacy residency at MSKCC will possess competencies that prepare them for future clinical, research or academic positions, leadership roles in oncology, and board certification in oncology pharmacy.

The Pediatric Oncology Specialty Residency provides advanced training in clinical therapeutics for the pediatric cancer patient. The main objectives of this one-year training program are to help residents:

  • Establish a firm knowledge base in pediatric cancer conditions, treatment options, antineoplastic pharmacology, and pharmacokinetics
  • Optimize outcomes in pediatric cancer patients through evidence-based, patient-centered medication therapy as an integral part of an interdisciplinary team
  • Foster clinical problem-solving skills
  • Provide an introduction to clinical research

Required Rotations

  • Orientation
  • Pediatric Hematology/Oncology: Inpatient
  • Pediatric Bone Marrow Transplant: Inpatient
  • Pediatric Bone Marrow Transplant: Outpatient
  • Pediatric Leukemia/Lymphoma Outpatient Clinic
  • Pediatric Neuro-Oncology Outpatient Clinic
  • Pediatric Neuroblastoma Outpatient Clinic
  • Pediatric Sarcoma Outpatient Clinic
  • Investigational Drug Services
  • Adult Leukemia: Inpatient

Longitudinal Learning Experiences

  • Clinical Research Project
  • Medication Use Policy
  • Medication Safety and Quality Management
  • Pharmacy Operations

Elective Rotations

During the two months of elective rotations, residents may repeat a previous rotation, begin a new rotation as approved by the program director or choose from the following rotations:

  • Long Term Follow Up (Survivorship) Clinic
  • Pediatric Intensive Care Rotation
  • Adult Oncology Rotation

Application Deadline

December 31st 2018

Length of Program

One year

Number of positions

Two

Eligibility

  • Successful completion of an ACPE accredited Doctor of Pharmacy program
  • Successful completion of an ASHP accredited PGY-1 Pharmacy Practice Residency
  • Eligibility for pharmacist licensure in New York State (Residents are required to obtain Pharmacist licensure in the State of New York)
  • Interview in the Personal Placement Service (PPS) at ASHP Midyear Clinical Meeting

How to Apply

Interested candidates should submit the following through Pharmacy Online Residency Centralized Application (PhORCAS):

  • Letter of interest explaining career goals
  • Three letters of recommendation (standard PHORCAS format)
  • Academic transcript
  • Curriculum Vitae

Additional Information

 

Contact

Sherry Mathew, Pharm.D., BCOP
Manager, Pediatric Clinical Pharmacy Services
Pediatric Oncology Pharmacy Residency Program Director
Memorial Sloan Kettering Cancer Center
1275 York Avenue, Schwartz 718
New York, NY 10065
mathews@mskcc.org
212-639-8803